A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis.
| Image |  |
|---|---|
| Description | scientific article published on 22 January 2016 |
| Author/s |
author: Kim A. Papp |
| Publication date | April 5, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |